Antidepressant may also reduce menopausal symptoms Just one week after the discovery that the antidepressant Paxil (paroxetine) may be able to help avert heart failure, fresh findings from the University of Florida in Jacksonville show that the drug may also alleviate menopausal symptoms. Just one week after the discovery that the antidepressant Paxil (paroxetine) may be able to help avert heart failure, fresh findings from the University of Florida in Jacksonville show that the drug may also alleviate menopausal symptoms. An initial trial lasted 12 weeks and showed that a 7.5 mg daily dose of paroxetine reduced weekly hot flashes by 44 compared with a placebo reduction of 37. A second trial lasted 24 weeks and found a 50 percent or greater reduction in vasomotor symptom (VMS) frequency among the 568 women aged 40 and older. According to lead author James Simon, MD from George Washington University, placebo treatments can be effective at treating vasomotor symptoms, which makes it particularly important to include placebo control groups in studies of VMS reduction. Although paroxetine was less effective than traditional treatments, the drug may prove useful for those patients for whom hormonal treatments are not an option, Simon told MedPage Today, adding that the FDA does not currently offer non-hormonal VMS treatments. "There are many women who are not candidates at all for hormonal therapy - they have hormone-dependent breast cancers or other absolute contraindications," Simon said. "But more importantly, many women choose not to use hormone treatment because they are inordinately afraid of the side effects and complications of those hormone treatments." While some side-effects were found in the 12-week study, such as weight gain or slight sexual dysfunction, those effects were nonexistent by week 24 of the second study. Paxil is most commonly used as an SSRI antidepressant. After consulting with their doctors, patients looking to buy Paxil can find inexpensive options from Canadian and international online pharmacies. The study highlights the need for non-hormonal VMS treatments and improved access to drug therapies for menopausal symptoms with fewer side effects. Simon recommends that women undergoing menopause - which typically arrives around 51 year old and is determined by 12 weeks of lapsed period - should ask their physicians before seeking hormonal treatments.

See also ...

• New study suggests Tamoxifen treatment should be extended to 10 years
• Aspirin could slow age-related cognitive decline in women
• Depression causes widespread work absences, studies find
• Paxil may help prevent heart failure
• Melatonin and exercise shown to reduce Alzheimer's symptoms in mice
• New schizophrenia treatment canceled due to poor results
• New osteoporosis treatment successful in mice, study says
• Yale uses biochemistry in an attempt to combat depression
• Scientists say creating an anti-heart disease vaccine could be possible
• Research shows progress toward creating Alzheimer's blood test
• New drug cocktail cures coke addiction in lab rats
• Algae extract may improve cholesterol levels
• There are as many undiscovered drugs as stars in the sky, researchers say
• Researchers develop new test for osteoporosis
• Statin medications may reduce the size of men's prostates
• Researchers find process that leads to development of arthritic condition
• Researchers find new treatment that may quell joint swelling
• Researchers develop new treatment for enlarged prostate
• New study shows antidepressants can alleviate arthritis pain
• Study uses stem cells to treat osteoporosis
• Statins equally as effective in women as men
• Blood sugar monitoring shows little benefit
• Use of cane reduces arthritic knee pain
• Researchers explain how statins may fight breast cancer
• Study pinpoints genetic sign of osteoarthritis
• Researcher talks arthritis cure
• Broad approach of new drug may prevent progression of Alzheimer's
• New osteoporosis medication fails in clinical trial
• Second biopsy may determine efficacy of breast cancer treatments
• New study confirms benefits of Lipitor
• Researchers find why some women are resistant to Tamoxifen
• Researchers work toward new drug to treat BPH
• Researchers discover source of inflammation that leads to arthritis
• Aggressive blood sugar control may provide no benefit for diabetics
• Researchers uncover process that potentially causes arthritis
• Bipolar disorder and schizophrenia share many brain similarities
• Researchers make important finding in drug-resistant breast cancer
• Study findings medication improve BPH symptoms
• Treating acid reflux is possible
• Researchers say treatment for acid reflux is effective
• South Asians are more likely to develop obesity-related health conditions like diabetes, study finds
• Aggressively lowering blood sugar may have few benefits for diabetics
• Stem cell therapy may be the future of osteoporosis treatment
• Controlling acid reflux shown to benefit patients with lung condition
• Clomid consumers might be affected by new fluoride research
• Nexium users often forced to make tough treatment decisions
• New fertility research might impact those who consume Clomid
• Fertility less affected by new chemo drug is good news for Clomid users
• People taking Nexium for acid reflux may have an�alternate solution
• Five foods that could increase Nexium need